Log in to save to my catalogue

Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therap...

Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therap...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2453692126

Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy

About this item

Full title

Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy

Publisher

BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd

Journal title

British journal of ophthalmology, 2022-01, Vol.106 (1), p.113-120

Language

English

Formats

Publication information

Publisher

BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

AimTo objectively assess disease activity and treatment response in patients with retinal vein occlusion (RVO), neovascular age-related macular degeneration (nAMD) and centre-involved diabetic macular oedema (DME), using artificial intelligence–based fluid quantification.MethodsPosthoc analysis of 2311 patients (11 151 spectral-domain optical coher...

Alternative Titles

Full title

Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2453692126

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2453692126

Other Identifiers

ISSN

0007-1161

E-ISSN

1468-2079

DOI

10.1136/bjophthalmol-2020-317416

How to access this item